Compare EQT & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQT | DGX |
|---|---|---|
| Founded | 1925 | 1967 |
| Country | United States | United States |
| Employees | 1873 | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5B | 25.9B |
| IPO Year | 1994 | 1996 |
| Metric | EQT | DGX |
|---|---|---|
| Price | $49.89 | $259.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 17 |
| Target Price | $67.00 | ★ $257.27 |
| AVG Volume (30 Days) | ★ 8.1M | 862.5K |
| Earning Date | 10-27-2026 | 10-22-2026 |
| Dividend Yield | ★ 1.38% | 1.35% |
| EPS Growth | ★ 635.56 | 13.78 |
| EPS | 3.14 | ★ 7.86 |
| Revenue | $8,644,211,000.00 | ★ $11,035,000,000.00 |
| Revenue This Year | $11.28 | $9.51 |
| Revenue Next Year | $30.91 | $4.45 |
| P/E Ratio | ★ $15.83 | $32.64 |
| Revenue Growth | ★ 63.92 | 11.78 |
| 52 Week Low | $47.94 | $171.18 |
| 52 Week High | $68.24 | $259.00 |
| Indicator | EQT | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 37.11 | 70.19 |
| Support Level | $48.77 | $227.47 |
| Resistance Level | $54.42 | N/A |
| Average True Range (ATR) | 1.96 | 7.93 |
| MACD | -0.67 | 1.55 |
| Stochastic Oscillator | 13.14 | 99.34 |
EQT is an independent natural gas production company. It focuses its operations in the cores of the Marcellus and Utica shales, located in the Appalachian Basin in the Eastern United States. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has three reportable segments: production, gathering, and transmission, which is now an operated joint venture with Blackstone. All the firm's operating revenue is generated in the US, with most revenue flowing from the Marcellus and through the sale of natural gas.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.